Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of sugammadex on depth-of-anesthesia monitoring
2009-010916-14Phase 4Completed
- Sponsor
- Antti Aho
- Start
- Feb 2009
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4 trial of Sugammadex (2 arms), sponsored by Antti Aho. Primary endpoint: Presence or absence of EMG. Started Feb 2009; status: completed.
02
Drugs
Sugammadex
Beyond the preview
Go deeper on 2009-010916-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010916-14.